Follow the money.Follow the referral.Follow the claim.

Healthcare fraud is usually imagined as a fake bill: a service that never happened, a patient who never existed. The federal enforcement record of the last quarter century shows something more structural. In case after case, investigators have had to reconstruct an arrangement — a compensation formula, a speaker fee, a technology subsidy, a joint venture, a management contract — and then trace how it reached a referral, a clinical decision, a claim and a payment. The bill is often the last link in the chain, not the first. E24L01L03

This investigation follows that chain. It draws on 25 fiscal years of Department of Justice enforcement statistics; representative federal matters from 2001 through October 2026; the Los Angeles prosecutions announced on October 22, 2026; a federal self-disclosure program announced the same day; and a Fresno False Claims Act case in which a 2025 settlement resolved allegations against a hospital system and its technology affiliate while litigation against other defendants continues. It also examines correspondence, preserved since 2011, in which a Fresno physician asked questions about technology access, governance and physician independence years before the federal case became public.

The cases share recurring questions about incentives and control. They are not one scheme, and nothing in the record reviewed here suggests that they are. A settlement in one case proves nothing about a defendant in another. Throughout, each statement is labeled by what supports it — a court record, a settlement, an allegation, a private historical document, or analysis — so that a defense lawyer, a prosecutor, a judge, a compliance officer, a physician and an ordinary reader can each tell what is known from what is alleged.

Why this matters now

Federal enforcement in this area is not slowing. For fiscal year 2025, DOJ reported more than $6.8 billion in False Claims Act settlements and judgments — which it described as the highest single-year total in the statute’s history — and a record 1,297 new qui tam suits filed by whistleblowers. More than $5.7 billion of the year’s total related to the healthcare industry. E22E23

Settled, no liability determination The pattern has continued through 2026. In January, Kaiser Permanente affiliates agreed to pay $556 million to resolve allegations that they submitted unsupported Medicare Advantage diagnosis codes. E31 In August, The Villages Health System agreed to a $541.5 million settlement of self-disclosed Medicare Advantage coding allegations. E32 In October, CVS agreed to pay $315 million to resolve Controlled Substances Act and False Claims Act allegations concerning opioid dispensing. E17 Each announcement states that the claims resolved were allegations only, with no determination of liability.

Charged, not adjudicated On October 22, 2026, DOJ announced charges against 15 defendants in Los Angeles, including six medical professionals, in matters it described as involving about $2 billion in fraudulent claims. E18 The same day, DOJ’s Civil Division and HHS opened a six-month pilot offering a predictable civil resolution to companies that disclose potential False Claims Act violations the government does not already know about. E25E26

Court order The legal machinery is being tested as well. On September 1, 2026, the Eleventh Circuit held that the Act’s qui tam provisions do not violate the Appointments Clause, and sent other constitutional challenges back to the trial court. L16 In California, a statute that took effect January 1, 2026 bars private-equity groups and hedge funds from controlling a list of clinical and business decisions in physician and dental practices — a reminder that the question of who controls medical judgment is current law, not history. A07

Taken together, these developments describe what can fairly be called a nationwide enforcement crackdown: not a single named federal operation, but a sustained federal focus on the arrangements behind healthcare claims. Across the country, enforcement is increasingly examining the arrangement behind the claim. The figures that follow show the scale of that effort. They do not show how much fraud exists.

Twenty-five years of enforcement, by the numbers

Verified public record DOJ’s fiscal year 2025 statistics publication reports annual False Claims Act settlements and judgments back to 1987. Adding its published annual totals for fiscal years 2001 through 2025 produces $77,953,204,612 across all client agencies. Matters for which HHS was the primary client agency account for $56,460,840,036 of that sum. The same 25 years recorded 14,954 new qui tam matters. These are KPSGILL.com’s calculations from DOJ’s table, not totals the department announced; all 25 annual rows were checked against the publication. E22

Three cautions govern every use of these numbers.

They measure resolutions, not fraud. A settlement amount is what parties agreed to pay to resolve allegations, often without any finding of liability; a judgment is what a court awarded. Neither is an estimate of how much fraud occurred, how much money was taken, or how much cash was collected. E22

The HHS series is a subset. Matters in which HHS was the primary client agency are already inside the all-agency total and must not be added to it. They are an agency classification, not a census of every healthcare case. E22

Coverage changed in fiscal year 2020. Beginning October 1, 2019, DOJ’s non-qui-tam totals include matters handled separately by U.S. Attorneys’ Offices, which earlier years did not capture. A peak reflects the timing of large resolutions and reporting coverage as much as conduct. E22

Whistleblowers drive much of this docket. New qui tam matters rose from 314 in fiscal year 2001 to 1,297 in fiscal year 2025, the highest figure in the series. E22E23 A qui tam suit is filed under seal. The government investigates and then decides whether to intervene, to decline, or — as in Fresno — to intervene as to some defendants and not others. The relator can continue litigating claims the government does not take over. L02

See the complete annual table and method

Anatomy of a healthcare enforcement case

Most significant healthcare enforcement matters require investigators to reconstruct the same sequence. The links carry different weight from case to case, but the questions recur. E24L01L03

Knowledge runs underneath every link. The False Claims Act requires that a defendant acted knowingly; the Anti-Kickback Statute requires knowing and willful conduct. What participants understood at each stage — and what warnings they received — often decides whether a questionable arrangement becomes a legal violation. L01L03L05

The chain also explains why ordinary-looking arrangements can become enforcement matters. Physician employment, medical-director agreements, consulting and speaker fees, management contracts, practice acquisitions, joint ventures, technology donations, clinical-integration payments and waived fees are lawful in many forms. Each can become a legal problem when the facts show that value moved to a referral source, that the value was connected to referrals or orders, that federal claims followed, and that the participants had the required state of mind.

Similarity between arrangements generates investigative questions. It does not itself prove illegality.

Los Angeles, October 2026: inside a $2 billion headline

Charged, not adjudicated On October 22, 2026, DOJ announced charges against 15 defendants in Los Angeles, including six medical professionals. The Central District of California release described “$2 billion in fraudulent claims to government and private health care programs”; DOJ’s national release said “over $1.8 billion,” under a headline reading “Nearly $2 Billion in Loss.” E18E19 Each figure aggregates distinct matters announced together. None is a conviction, a judgment, a single scheme, or a finding of loss to taxpayers. DOJ’s own release states that indictments, complaints and informations merely contain allegations, and that every defendant is presumed innocent. E18

Most of the headline comes from one case. A substance-abuse-treatment indictment alleges more than $1.6 billion billed to private insurance companies through patient recruitment, inducements and sham treatment — claims against private insurers, not federal programs. A facility area manager connected to that enterprise has pleaded guilty and admitted assisting in submitting $199 million in fraudulent claims. His plea binds him alone, and the $199 million overlaps the enterprise figure rather than adding to it. E18

The other matters involve different patients, payers, procedural stages and laws: three hospice schemes that DOJ says billed Medicare more than $138 million, charged by complaint and by information; separate indictments of two physicians accused of accepting kickbacks to authorize genetic-testing orders; an information alleging kickbacks for referrals to a rehabilitation facility; an indictment in an existing Medi-Cal pharmacy prosecution alleging about $269 million in claims, of which Medi-Cal paid at least about $178.7 million; and an indictment concerning the sale of prescription-drug samples. E18

Submitted is not the same as paid

The arterial-procedure case shows why the distinction matters. The indictment, returned October 20, 2026 in the Central District of California (No. 2:26-cr-00668-JFW), charges a cardiothoracic surgeon and a chiropractor with healthcare fraud related to atherectomies performed at two Los Angeles clinics. It alleges medically unnecessary procedures, kickbacks, and claims that misidentified the rendering provider. Paragraph 21(i) alleges that from about January 2016 through August 2023 the clinics submitted approximately $134,955,000 in Medicare claims, and that Medicare paid at least approximately $54,817,000. E20

Abbreviated accounts round the first figure to $134 million or $135 million. The precise description is about $135 million submitted and at least $54.8 million allegedly paid. Both are allegations in a charging document; neither is a proven loss. DOJ says data analytics identified unusual atherectomy billing. That is an investigative starting point, not proof: clinical records, patient circumstances, the identity of the rendering professional and intent must still be established in court. E18E20E21

The case also invites a false comparison with Operation Spinal Cap, the earlier Southern California prosecution in which a hospital owner pleaded guilty and was sentenced to 63 months in prison. That case concerned spinal surgeries billed principally to California workers’ compensation. The October 2026 case concerns Medicare, a different procedure and different defendants. Neither establishes any fact about Fresno. E11E20

Read the case-by-case breakdown of the Los Angeles actions

Enforcement is expanding — but so are opportunities to self-correct

Regulatory guidance The same day as the Los Angeles announcement, DOJ’s Civil Division and HHS — its Office of the General Counsel, Office of Inspector General and the Centers for Medicare & Medicaid Services — launched the Healthcare False Claims Act Self-Disclosure Pilot Program. E25E26

Window

Six months. Submissions are due by 11:59 p.m. on April 22, 2027. Late or partial submissions are not accepted.

Who may disclose

Providers, suppliers, manufacturers, payors and related entities paid directly or indirectly by HHS federal healthcare programs.

What qualifies

A potential FCA violation previously unknown to the federal government. Conduct the government already knows about may earn ordinary cooperation credit under Justice Manual §4-4.112, but not a pilot resolution.

What must be submitted

A full description of the conduct and the requirements violated, documents showing how it operated, remedial measures, financial information for a base repayment, a certification, and a contact.

What the company receives

A coordinated civil release under the FCA and specified HHS authorities, with no factual admissions. HHS-OIG will not require a corporate integrity agreement; CMS will not impose civil monetary penalties or seek revocation.

What it pays

1.25 to 1.6 times a base repayment, depending on timeliness, duration and scope, senior-leadership involvement, financial benefit and successor-liability circumstances. For kickbacks, the base considers remuneration and revenue rather than claims paid.

What it does not cover

Criminal conduct, which goes to DOJ's National Fraud Enforcement Division under a separate coordination policy.

Sources: DOJ announcement and protocol, October 22, 2026. E25E26

The pilot belongs in an enforcement story for a structural reason. The chain that prosecutors reconstruct after the fact — arrangement, benefit, referral, claim, payment — is exactly what a disclosing company must document for itself: the conduct, the documents showing how it operated, the money, and the fix. The protocol’s own illustrations are a hospital that discovers it delayed laboratory orders to work around a Medicare billing rule, and an acquiring company that finds a legacy kickback problem after closing. E26 The 2026 Villages Health settlement shows the other side of the ledger: a provider group that self-disclosed coding problems still agreed to a $541.5 million settlement, approved by a bankruptcy court, with cooperation credit. E32

Analytical inference Nothing in the pilot suggests that any organization discussed in this investigation is eligible or has made a disclosure. By its terms the pilot is limited to potential violations previously unknown to the federal government. Whether a particular matter qualifies depends on the actual conduct and on what the government already knows.

Twenty-five years of cases: how the mechanisms changed

The matters below span 2001 to October 2026. They are representative, not exhaustive, and each was chosen because it exposes a different mechanism. Read the label on each card first: a guilty plea, a judgment, a settlement with admissions, a settlement without any determination of liability, a deferred or non-prosecution agreement, and a pending charge are different legal events. Amounts are not comparable across cards — criminal fines, civil payments, forfeitures, judgments, submitted claims and paid claims measure different things — and they should not be added to one another or to the annual statistics, where some already appear.

Three patterns emerge from the sequence.

The arrangement moved closer to the clinical decision. Early matters centered on drug pricing, cost reports and marketing benefits. Later ones placed the mechanism inside the clinical workflow. Practice Fusion admitted that pharmaceutical-sponsored alerts in its EHR software were designed to influence opioid prescribing. The 2026 Medicare Advantage settlements resolved allegations of unsupported diagnosis codes, including codes allegedly added to records after visits. E12E31E32

Valuation became evidence. In Tuomey, Halifax, Community Health Network and the 2014 DaVita matter, the dispute turned on whether compensation or deal terms reflected fair market value for real work, and on what the valuation inputs actually were. A favorable valuation built on incomplete inputs did not end the inquiry. E05E06E08E15

Whistleblowers carried cases the government did not. Biogen’s $900 million settlement came in a case the relator litigated without federal intervention. Nonintervention is not exoneration, and intervention is not a finding. E14L02

The comparison is useful precisely because it is limited. Was the work real? Was the compensation supported? Did a benefit depend on referrals? Who controlled the clinical decision? Were the claim and the rendering-provider information accurate? Those answers must come from the arrangement under examination. Resemblance to an earlier case supplies questions, not a verdict.

The Fresno Files

A settlement, an unresolved federal case, and a decade-plus paper trail

Fresno’s record contains several historically connected but legally distinct things: a federal settlement with a hospital system and its technology affiliate; a continuing False Claims Act case against different defendants; and a private archive of correspondence that predates both. They have to be read together, and kept apart.

The case is United States ex rel. Terpening v. Fresno Community Hospital and Medical Center, et al., No. 1:19-cv-01699-JLT-HBK, in the U.S. District Court for the Eastern District of California. The court’s electronic docket uses the short title “Terpening v. United States et al”; the case is brought on the government’s behalf, and the case number is the reliable identifier. F02F12 The relator — described in the settlement agreement as a PNA employee from 2011 to 2017 — filed it under seal on December 4, 2019. F02 Official records identify the litigants by name. This account uses roles for individuals and names for organizations, as the methodology explains.

The May 2025 settlement

Settled, no liability determination Corporate integrity agreement On May 14, 2025, the U.S. Attorney’s Office for the Eastern District of California announced that Fresno Community Hospital and Medical Center, doing business as Community Health System (CHS), and its affiliate Physician Network Advantage, Inc. (PNA) had agreed to pay $31.5 million to resolve allegations that they violated the False Claims Act by providing financial benefits to referring physicians. The release stated that the claims resolved were allegations only, with no determination of liability. F01

The executed agreement is more precise, and its numbers must not be added together. F02

Government contention The agreement defines four categories of “Covered Conduct,” each introduced by the phrase “the United States contends.” F02

The United States contended that this conduct violated the Anti-Kickback Statute and caused false claims, and that it created financial relationships between CHS and physician members of the Santé Health Foundation and the faculty medical group that did not satisfy any Stark Law exception. The agreement states that it is “neither an admission of liability by CHS or PNA, nor a concession by the United States that its claims are not well founded,” and that “CHS and PNA deny the allegations.” CHS also entered a five-year corporate integrity agreement with HHS-OIG, effective May 7, 2025, with estimated completion in May 2030. F02F03F10

The settlement included denials and did not constitute a judicial determination of liability.

The federal case did not end with the settlement

Court order Pending litigation The government’s May 2025 election drew three distinct lines. It intervened for purposes of settlement as to CHS and PNA. It declined to intervene as to six individual defendants. And it elected “not to intervene at this time” as to Santé Health System, Santé Health Foundation, Central California Faculty Medical Group and two physician defendants, telling the court that its investigation would continue as to them. F04 That last category is not a declination. It is a dated procedural position; the record reviewed here does not establish the present status of any government investigation.

The June 2025 dismissal order dismissed the claims against CHS and PNA — with prejudice as to the relator, and as to the United States with prejudice for the Covered Conduct and without prejudice otherwise — dismissed the six individuals, and expressly dismissed no one else. The settlement had already excluded the five remaining defendants from the relator’s releases. F05F02

The current PACER docket report, generated October 25, 2026 at 3:30 p.m. Pacific and running through docket entry 101 of October 19, 2026, shows what followed. F12

Sources: PACER docket report and court orders. F12F04F05F06F07

A docket proves procedural events. A pleading proves what a party alleged. Evidence proves facts. Only a judgment establishes an adjudicated outcome. This investigation has not yet reviewed the text of the First Amended Complaint, and nothing here describes its paragraph-level allegations or predicts the ruling on the pending motion. In November 2025 the district judge noted that a judicial resource emergency had left about 100 civil motions under submission and that a decision could take six months or more. F12

Read the full Fresno case file: docket chronology, settlement terms and schedule

Before the federal case

Questions about technology, physician independence, transparency and control

Private historical record Correspondence preserved in a private archive shows that some of the questions later central to Fresno enforcement — who controls the technology physicians use, who controls clinical decisions, and who can see the records that explain a nonprofit’s structure — were being asked in writing years before the federal case became public. The archive was preserved by a Fresno physician; see the disclosure below. Its records establish what was asked, asserted and answered at the time. They do not establish that those assertions were correct, and they are not proof of the allegations later resolved or still pending. None of the reviewed correspondence addresses the HQ2 venue, the EHR cost-sharing arrangements or the clinical-integration grants that the settlement describes; the December 2011 messages argued, if anything, that PNA’s prices were too high. H04F02

The document trail

Each record below is presented with what it establishes and what it does not. That second list is not a hedge. It is the part of the evidence a hostile reader will test first.

1. December 2011Technology inquiryEmail correspondencePrivate historical record

   What it establishes

   • A PNA sales executive wrote that “Physician Network Advantage is the exclusive provider for EpicCare in the Fresno and Clovis area,” with three pilot sites and a general release expected in 2012.
   • A physician asked about price, a five-year commitment, data ownership, confidentiality of practice finances, interfaces with outside labs and imaging, and what would happen if hospital privileges changed.
   • The physician argued that PNA's prices exceeded competitors' and that exceptions to the kickback law allowed hospitals to subsidize physicians' EHR licensing.
   • PNA replied in January 2012 that the questions were being reviewed and proposed further steps.

   What it does not establish

   • That any exclusivity was unlawful or anticompetitive.
   • A warning about the EHR subsidies later described in the settlement. The messages argued that prices were too high.
   • Actual contract terms or prices. A $25,000 interface figure in the exchange was a hypothetical, not a quote.
   • That any physician was required to refer in exchange for access.

   Source: H04

2. October 8, 2015Seven-page governance letterLetter, hand-delivery notationPrivate historical record

   What it establishes

   • The text of the concerns and the date they were put in writing.
   • That the letter was circulated by email the same day.
   • That its author asked for access to the foundation's exemption application and related records.

   What it does not establish

   • That its legal interpretations are correct; several require qualification.
   • That any particular director read it.
   • Any violation of law, or any connection to the conduct later settled.

   Source: H01H02

3. October 2015Inspection correspondenceEmail correspondencePrivate historical record

   What it establishes

   • A request for the foundation's exemption documents.
   • An October 22 offer to inspect the Form 1023, stating: “As we discussed there will be no copying of the exemption application at this time.”
   • The physician's same-day reply: “I don't need to copy,” with a request to take notes; then October 26 scheduling of the visit.

   What it does not establish

   • What happened at the inspection.
   • A completed violation of federal disclosure rules; that depends on facts the exchange does not settle.
   • The content of a separately referenced written response, which has not been recovered.

   Source: H03

4. March 2016Follow-up correspondenceEmail correspondencePrivate historical record

   What it establishes

   • A meeting with PNA, and an offer to clarify data exchange within and across EHR systems.
   • A senior PNA executive's brief reply, “Good luck with your initiatives,” sent before the physician's longer follow-up that evening.

   What it does not establish

   • Agreement with anything in the later message, which had not yet been sent.
   • That an out-of-state kickback settlement the physician cited as an analogy described Fresno.
   • A 2016 FBI call the physician reported; it is not independently corroborated.

   Source: H05

5. June 2019An FBI meeting, subject not establishedEmail correspondence with an FBI agentUnresolved

   What it establishes

   • A June 10 request to meet in person with two agents; a June 11 exchange settling on Friday at 9 a.m.
   • A meeting on or about June 14, 2019, corroborated by a June 16 thank-you and a June 18 reply.
   • The physician described his subject as false-claims allegations “which also resulted in violations of statutes enforced by DEA.”

   What it does not establish

   • That it concerned any Fresno organization. None is named, and the subject described does not appear in the settlement's covered conduct.
   • Any causal connection to the later case, or that investigators used what they were told.
   • Relator status or entitlement to any share of a recovery.

   Source: H06

6. December 4, 2019Qui tam filingSealed complaintVerified public record

   What it establishes

   • A relator, described in the settlement as a PNA employee from 2011 to 2017, filed the action under seal.
   • The named defendants included the hospital system, PNA, both Santé entities, the faculty medical group and individuals.

   What it does not establish

   • The truth of any allegation in the complaint.

   Source: F02F12

7. May 2025SettlementExecuted agreement and DOJ releaseSettled, no liability determination

   What it establishes

   • The terms, the four categories of covered conduct stated as government contentions, the denials, and the corporate integrity agreement.
   • That the relator's releases excluded the five remaining defendants.

   What it does not establish

   • Liability of the settling parties.
   • Anything about the liability of the remaining defendants.
   • The total of any federal loss.

   Source: F01F02F03

8. 2025–2026Continuing federal litigationPACER docket and court ordersPending litigation

   What it establishes

   • A First Amended Complaint (September 15, 2025) and a fully briefed, undecided motion to dismiss.
   • About 1.8 million pages produced; deposition protocols; an October 2026 conference the court set to address a spoliation issue and the postponement of two depositions.

   What it does not establish

   • Any finding of spoliation.
   • The merits, or how the court will rule on the motion.
   • Current deposition dates, pending the court's written order.

   Source: F12F06F07

The October 8, 2015 letter, in its own words

Private historical record The seven-page open letter, titled “Depiction of Business of Medicine in the Shades of Grey,” was addressed to Santé Health System’s chief executive, whom the letter describes as the foundation’s registered agent. It bears a hand-delivery notation — the author’s own record, not a receipt — and an email sent the same day circulated it to local reporters. H01H02

The letter is valuable as a dated account of what one physician asked an institution to address: who may make or override a clinical decision, who governs a nonprofit medical foundation, and who may inspect the records that explain its structure. It also contains sweeping characterizations and legal interpretations that later authorities qualify — on California’s medical-foundation exemption, hospital-affiliated foundations, medical directors and a superseded tax-procedure citation. KPSGILL.com presents it as historical text, attributes its conclusions to its author, and sets out the qualifications in the full case file. H01A01A02A03

June 2019: an FBI meeting whose subject the record does not establish

Private historical record Unresolved The archive contains a short email exchange with an FBI agent: a June 10, 2019 request to meet in person with two agents; a June 11 exchange settling on Friday at 9 a.m.; a June 16 thank-you; and a June 18 reply naming the second agent and a point of contact. The Friday in question was June 14. The messages support a meeting on or about June 14, 2019 — nearly six months before the December 4, 2019 qui tam filing. H06F02

The recovered correspondence documents federal contact months before the later qui tam action was filed. The currently available record does not establish the causal relationship, if any, between that meeting and the later litigation. The messages describe the subject only as the physician’s “false claims allegations,” which he said “also resulted in violations of statutes enforced by DEA” — a subject that does not appear in the Fresno settlement’s covered conduct. No message names Santé, Community, PNA or the transactions later at issue, and none shows what was provided, whether investigators used it, or that the meeting concerned this case at all. H06F02

Separately, DOJ’s May 2025 announcement credited assistance from the FBI and the U.S. Postal Service Office of Inspector General in the Fresno resolution, so a claim that the FBI did nothing would contradict the public record. The record does not connect that assistance to the June 2019 meeting. F01

When concerns appear years before enforcement

Analytical inference The Fresno archive is best read as a record of early questions, not as retrospective proof. That distinction raises practical questions that apply to any institution:

• What constitutes meaningful notice, and to whom must it be given?
• What should an institution do when a physician raises a concern in writing?
• How should a board investigate a potential conflict involving its own sponsors?
• How should EHR subsidies, contributions and selection criteria be documented?
• How can clinical independence be protected in practice, not just in contract language?
• When does a complaint become something a compliance officer must investigate?
• What records will allow a later reviewer to determine what actually happened?

Contemporaneous concerns can become important evidence of notice, knowledge, institutional response and chronology — but only when they are linked to the conduct and claims actually at issue. Under Schutte, the False Claims Act’s knowledge inquiry looks to what defendants actually knew and believed when claims were submitted. Receipt of an accusation does not establish agreement with it, or knowledge that any particular claim was false. L05

A tax return is a map, not a verdict

Verified public record The Santé Health Foundation’s federal returns are public. ProPublica’s Nonprofit Explorer, which extracts IRS e-file data, lists 2018 contributions of $26,405,002 for the foundation and shows more than one filing for that tax year. F13 Returns of this kind report independent contractors and the services they provided, and can direct attention to particular contracts and accounting records. Standing alone, they do not establish a fair-market-value failure, a referral link, unlawful remuneration, knowledge or a false claim, and disclosure on a public return cuts against any inference that the entries themselves prove concealment.

Unresolved A privately supplied copy of the 2018 return reviewed for this investigation contains figures that have not been matched to the IRS-filed return. KPSGILL.com is withholding those figures until they are reconciled against the authenticated filing and any amended return. H07

The laws behind the crackdown

Four bodies of law recur in these cases, along with a set of technology-donation rules that sit between them. They are not interchangeable, and each must be applied to the right entity, the right transaction and the right period. What follows is general legal information, not legal advice.

Follow the money: a reusable investigative checklist

KPSGILL.com uses these questions for every financial arrangement it examines. They are the chain, translated into evidence requests. An unsatisfying answer to any of them is a reason to look further, not a conclusion.

Compliance lessons: controls that can be checked

These controls follow from the legal distinctions above. Their inclusion does not imply that any institution discussed here lacks them. E30

Keep a complete arrangements register. Record the actual hospital, medical group, foundation, management company, vendor and individual parties to every arrangement with a referral source; the consideration, the services and the renewal dates; and any decision rights reserved to either side. Reconcile amendments and side agreements with the operating contract.

Review referral-source arrangements independently. Assess the Stark Law, the Anti-Kickback Statute, state referral restrictions and corporate-practice rules separately. A favorable analysis under one cannot substitute for the others, and the reviewer must be able to question the business sponsor. L08L11

Verify performance and payment. For consulting, directorships and administrative services, retain the work actually performed, the documented need for it, and the basis for compensation. Compare invoices and bank transactions with the agreement. Paper descriptions offer little assurance when payment and performance diverge.

Audit EHR contributions and restrictions. Preserve donor invoices, cost allocations, recipient payments and their dates, certification and interoperability records. Match each donation or update to the rule in force at the time, and test whether referral-neutral selection criteria operate as written. L09L10A06

Make clinical independence observable. Identify who can approve treatment, direct referrals, determine clinical competency and control the medical record. Review whether scheduling, credentialing, compensation or technology access creates indirect pressure, and examine reserved contractual powers as well as decisions already made. L12A04A07

Give concerns an accountable review. Preserve the complete record, assign responsibility for investigating, record competing explanations and verify corrective action. Do not treat a complaint as proof; do not treat its author’s disagreement with management as a reason to disregard it.

Trace claims before calculating losses. Identify the payer, service, submission, representation, payment and any refund or duplication. An estimate should state its assumptions and its uncertainty.

Corporate integrity agreement These controls already have a concrete form in Fresno. The five-year corporate integrity agreement that CHS signed requires compliance leadership with board access, management certifications, training, independent review, a tracking system for arrangements with referral sources, documentation of business rationale and fair market value, and review of new or renewed arrangements before payment. F10F03 The national lesson is the same one the agreement encodes: test performance against paperwork, and keep the records that let someone else do it.

What the records corrected

This edition replaces earlier drafts. Where original records or the current docket changed an earlier statement, the change is shown here. Corrections are part of the method, not a footnote to it.

Evidence gaps: what would change this assessment

These are defined requests for records, not invitations to fill missing facts with suspicion.

1. The First Amended Complaint (Dkt. 70)A defendant-by-defendant, count-by-count account of what is now alleged.
2. The written order after the October 19, 2026 conferenceThe status of the spoliation issue and the rescheduled depositions.
3. A ruling on the motion to dismiss (Dkt. 74)Which claims proceed.
4. Executed agreements, valuations, invoices and performance recordsWhether consideration, services and stated purpose match for each challenged arrangement.
5. EHR donor-cost and recipient-contribution ledgersWhether each donation or update met the rules in force at the time.
6. Claims and referral data linked to specific arrangementsFalsity, causation, materiality and any defensible loss figure.
7. The IRS-filed 2018 Form 990 and any amended returnWhether figures in the privately supplied copy match the filed return. A public database lists more than one filing for that tax year.
8. Materials provided at the June 2019 meeting, or an agency record of its subjectWhether the meeting concerned these organizations at all.
9. The original 2010 inquiry and the separately referenced 2015 written responseThe earliest chronology and the full institutional exchange.
10. Unreviewed historical attachments; 2021 to 2023 coverageWhether the historical picture changes when those originals are examined.
11. Responses from the partiesThis edition reports their positions as stated in the settlement and court record. KPSGILL.com will publish responses it receives.

Why this matters

Healthcare fraud enforcement is increasingly not only about whether a service occurred. It can turn on the architecture around the service: who financed the relationship; who controlled referrals; who controlled the technology; who controlled medical judgment; what economic benefit moved; what services were actually performed; how physicians were paid; how claims reached federal programs; what organizations knew; whether warnings were investigated; and whether ordinary business records can reconstruct the transaction afterward.

That is the lesson of 25 years of cases, and it cuts in both directions. An arrangement with a reassuring label — “EHR subsidy,” “clinical integration,” “administrative services,” “education” — is not lawful because of the label. An arrangement that resembles one in an earlier case is not unlawful because of the resemblance. The answer is in the records.

For patients and physicians, the test is whether a healthcare arrangement remains explainable from beginning to end. For institutions, it is whether an independent reviewer could reconstruct that explanation from ordinary records. A structure that depends on nobody seeing the whole transaction is hard to supervise long before any court reaches a legal conclusion.

The most revealing healthcare investigation may begin long before the claim is submitted. It begins with the arrangement that made the claim possible.

Method and sources

This investigation relies, in order of priority, on the current PACER docket; the executed federal settlement; federal court orders; DOJ and U.S. Attorney releases; HHS-OIG records; statutes and regulations; published judicial opinions; original documents in a private archive; contemporaneous correspondence; and earlier KPSGILL.com research. A newer primary source controls over an older secondary account. Individuals are identified by role; organizations, courts, agencies, case numbers and amounts are named so the account can be checked. Official records linked here identify litigants by name — this is editorial minimization, not anonymity. This edition does not include new statements from the parties; their positions are reported as stated in the settlement agreement and the court record, and KPSGILL.com will publish responses it receives.

Read the full methodology Open the source ledger

Reviewed and approved for publication by Kanwar Partap Singh Gill, MD.